PAPER
Direct Access to Functionalized Cyclic Enones
3029
1H NMR (300 MHz, CDCl3): d = 6.52 (dd, J = 10.0, 2.2 Hz, 1 H),
5.72 (d, J = 10.0 Hz, 1 H), 3.65–3.55 (m, 4 H), 2.83–2.78 (dd,
J = 12.6, 4.3 Hz, 1 H), 2.58–2.51 (m, 1 H), 2.43–2.22 (m, 5 H),
2.01–1.94 (m, 1 H), 1.55 (t, J = 13.7 Hz, 1 H), 1.10 (s, 3 H), 1.08 (s,
3 H).
13C NMR (75 MHz, CDCl3): d = 200.44, 158.81, 126.51, 66.77,
57.75, 53.72, 40.85, 40.13, 33.34, 30.36, 25.16.
Yield: 21 mg (65%); white solid; mp 85 °C (subl.); Rf = 0.76
(EtOAc–PE, 1:1).
1H NMR (300 MHz, CDCl3): d = 4.35 (d, J = 11.8 Hz, 1 H), 3.60 (t,
J = 4.61 Hz, 4 H), 3.36 (d, J = 11.8 Hz, 1 H), 2.50–2.48 (m, 1 H),
2.41–2.35 (m, 6 H), 2.23–2.21 (m, 2 H), 2.05 (dt, J = 13.38, 3.15
Hz, 1 H), 1.63–1.46 (m, 2 H), 1.33–1.20 (m, 7 H), 1.05 (s, 3 H),
0.95 (s, 3 H).
MS (EI): m/z (%) = 223 (10) [M+], 208 (2), 176 (2), 136 (10), 121
(6), 100 (100), 93 (4), 56 810), 41 (10).
13C NMR (75 MHz, CDCl3): d = 212.48, 73.37, 67.18, 62.85, 62.75,
55.62, 51.61, 50.87, 42.13, 38.93, 37.11, 34.92, 34.41, 30.88, 27.36,
22.66, 20.96.
HRMS (EI): m/z calcd for C13H21NO2: 223.1572; found: 223.1570.
MS (EI): m/z (%) = 321 (4) [M+], 293 (3), 222 (4), 208 (5), 197 (7),
[4,4-Bis(morpholinomethyl)-5-oxocyclopent-1-enyl]methyl
Acetate (23)
Yield: 134 mg (76%); pale-brown oil; Rf = 0.16 (EtOAc–PE, 1:1).
1H NMR (300 MHz, CDCl3): d = 7.57–7.55 (m, 1 H), 4.62–4.60 (m,
2 H), 3.52–3.58 (m, 8 H), 2.7 (br s, 2 H), 2.51–2.48 (m, 2 H), 2.38–
2.26 (m, 10 H), 2.05 (s, 3 H).
177 (2), 164 (3), 149 (4), 140 (6), 100 (100).
HRMS (EI): m/z calcd for C19H31NO3: 321.2304; found: 321.2306.
Anal. Calcd. for C19H31NO3: C, 70.99; H, 9.72. Found: C, 71.02; H,
9.85.
[4-Methyl(N-piperidinyl)]-1,7,7-trimethyl-6-oxatricy-
clo[6.2.2.04,9]dodecan-3-one (29)
Yield: 122 mg (85%); white solid; mp 89 °C (subl.); Rf = 0.85
13C NMR (75 MHz, CDCl3): d = 210.99, 170.41, 161.71, 140.18,
66.97, 63.06, 57.77, 55.36, 53.07, 36.53, 20.69.
(EtOAc–PE, 1:1).
ESI-MS: m/z = 375 [M + Na+].
1H NMR (300 MHz, CDCl3): d = 4.26 (d, J = 11.8 Hz, 1 H), 3.38 (d,
J = 11.8 Hz, 1 H), 2.50–2.48 (m, 1 H), 2.41–2.35 (m, 5 H), 2.23–
2.05 (m, 4 H), 1.63–1.43 (m, 7 H), 1.33–1.17 (m, 8 H), 1.05 (s,
3 H), 0.95 (s, 3 H).
[2-Methyl-5,5-bis(morpholinomethyl)-6-oxocyclohex-1-
enyl]methyl Acetate (25)
Reaction scale: 0.2 mmol.
Yield: 26 mg (63%); pale-brown oil; Rf = 0.19 (EtOAc–PE, 1:1).
13C NMR (75 MHz, CDCl3): d = 213.02, 73.38, 62.69, 62.57, 56.96,
51.72, 51.39, 42.22, 39.06, 37.15, 34.26, 30.92, 27.41, 26.54, 22.80,
21.00.
1H NMR (300 MHz, CDCl3): d = 4.83–4.65 (m, 2 H), 3.82–3.55 (m,
8 H), 2.70 (br s, 1 H), 2.48–2.22 (m, 15 H), 2.05 (s, 3 H), 1.94 (s,
3 H).
ESI-MS: m/z = 342 [M + Na+].
13C NMR (75 MHz, CDCl3): d = 197.70, 170.96, 162.62, 130.01,
68.86, 57.96, 53.87, 46.63, 43.19, 41.73, 31.96, 21.19, 20.96.
Anal. Calcd. for C20H33NO2: C, 75.19; H, 10.41. Found: C, 75.02;
H, 10.65.
ESI-MS: m/z = 403 [M + Na+].
Amino-Group Elimination; General Procedure
To a solution of amine (1 mmol) in anhyd MeCN (3 mL) under ar-
gon at r.t., was added freshly distilled AcCl (1.6 mL, 2 mmol). The
mixture was kept under argon and stirred for a further 17 h. CH2Cl2
(10 mL) was added and the mixture was washed with sat. NaHCO3
(5 mL) and brine (5 mL). The pure products were obtained after col-
umn chromatography (EtOAc–PE) on silica.
[3,3-Dimethyl-5-(morpholinomethyl)-6-oxocyclohex-1-
enyl]methyl Acetate (32)
Yield: 253 mg (86%); colorless oil; Rf = 0.7 (EtOAc–PE, 1:1).
1H NMR (300 MHz, CDCl3): d = 6.53 (s, 1 H), 4.62–4.57 (m, 2 H),
3.69–3.64 (m, 4 H), 2.90 (dd, J = 9.5, 3.3 Hz, 1 H), 2.70–2.61 (m,
1 H), 2.50–2.45 (m, 2 H), 2.38–2.31 (m, 3 H) 2.05–2.00 (m, 1 H),
2.01 (s, 3 H), 1.61 (t, J = 10.3 Hz, 1 H), 1.16 (s, 3 H), 1.13 (s, 3 H).
3,3-Dimethyl-5-methylene-6-oxocyclohex-1-enyl)methyl Ace-
tate (34)
Yield: 148 mg (71%); colorless oil; Rf = 0.7 (EtOAc–PE, 1:1).
13C NMR (75 MHz, CDCl3): d = 198.85, 170.55, 156.73, 131.09,
66.65, 61.33, 57.75, 53.72, 40.87, 40.25, 33.15, 30.57, 25.16, 20.89.
1H NMR (300 MHz, CDCl3): d = 6.71 (s, 1 H), 6.03 (br q, 1 H), 5.27
(br q, 1 H), 4.72 (d, J = 1.14 Hz, 2 H), 2.54 (s, 2 H), 2.05 (s, 3 H),
1.12 (s, 6 H).
13C NMR (75 MHz, CDCl3): d = 186.89, 170.58, 157.52, 140.79,
132.08, 121.80, 61.33, 45.11, 34.25, 28.15, 20.92.
MS (EI): m/z(%) = 295 (4) [M+], 235 (9), 220 (5), 182 (3), 100
(100), 81 (5), 69 (6), 56 (6), 43 (5).
HRMS (EI): m/z calcd for C16H25NO4: 295.1784; found: 295.1773.
{6-Oxo-5-[(piperidin-1-yl)methyl]cyclohex-1-enyl}methyl Ace-
tate (33)
Yield: 218 mg (82%); pale-yellow oil; Rf = 0.6 (EtOAc–PE, 1:1).
ESI-MS: m/z = 203 [M + Na+].
1H NMR (300 MHz, CDCl3): d = 6.91 (br t, J = 3.6 Hz, 1 H), 4.73–
4.61 (m, 2 H), 2.71 (dd, J = 12.5, 4.6 Hz, 1 H), 2.54–2.46 (m, 1 H),
2.45–2.15 (m, 8 H), 2.02 (s, 3 H), 1.85–1.70 (m, 1 H), 1.57–1.45
(m, 4 H), 1.42–1.35 (m, 2 H).
13C NMR (75 MHz, CDCl3): d = 199.63, 170.66, 147.89, 134.00,
61.47, 57.85, 54.75, 44.57, 26.76, 25.88, 24.83, 24.24, 20.91.
(5-Methylene-6-oxocyclohex-1-enyl)methyl Acetate (35)
Yield: 114 mg (63%); colorless oil; Rf = 0.8 (EtOAc–PE, 1:1).
1H NMR (300 MHz, CDCl3): d = 7.02 (t, J = 3.23 Hz, 1 H), 5.99 (d,
J = 1.05 Hz, 1 H), 5.30–5.28 (m, 1 H), 4.78 (d, J = 1.05 Hz, 2 H),
2.71 (t, J = 4.74 Hz, 2 H), 2.49–2.44 (m, 2 H), 2.06 (s, 3 H).
13C NMR (75 MHz, CDCl3): d = 187.24, 170.70, 148.28, 142.34,
135.14, 120.67, 61.45, 30.71, 25.80, 20.94.
ESI-MS: m/z = 231 [M + Na+].
ESI-MS: m/z = 298 [M + Na+].
[4-Methyl(N-morpholino)]-1,7,7-trimethyl-6-oxatricy-
clo[6.2.2.04,9]dodecan-3-one (27)
Reaction scale: 0.1 mmol.
Mannich Reaction Followed by Elimination; General Proce-
dure
To a solution of aminal (1 mmol) and cyclic enone (1.2 mmol) in
anhyd MeCN (3 mL) under argon at r.t. was added freshly distilled
Synthesis 2006, No. 18, 3025–3030 © Thieme Stuttgart · New York